Intervention for Sustained Testing and Retention Among HIV-infected Patients
iSTAR
2 other identifiers
interventional
400
1 country
1
Brief Summary
The purpose of this study is to evaluate the comparative effectiveness of a congregation, clinic and integrated case management-based intervention for sustainable testing and retention on linkage to care, engagement, retention and viral load suppression of women and children infected with HIV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Jul 2016
Typical duration for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 6, 2017
CompletedFirst Posted
Study publicly available on registry
January 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedJanuary 11, 2017
January 1, 2017
3.7 years
January 6, 2017
January 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Linkage in care
Linkage in care is defined as the percentage of participants with at least one HIV medical care visit following HIV diagnosis.
1 month
Retention in care
Retention is defined as the percentages of participants with two or more documented viral load measurement during the 12 months following enrollment.
12 months
Secondary Outcomes (2)
ART Initiation
1 month
Viral Suppression
12 months
Study Arms (2)
Control group
NO INTERVENTIONHIV-infected participants identified from the churches randomized to CG will be referred to PEPFAR-supported HIV clinics that provide comprehensive care including counseling, laboratory testing, ART and ongoing support during treatment as the standard of care. The study team will not be involved in their care beyond data collection.
iSTAR
EXPERIMENTALHIV-infected participants identified from the churches clustered within the randomized health facilities will receive interventions from the study team.
Interventions
Each component of the iSTAR intervention targets a specific point along the HIV continuum: confidential, onsite integrated laboratory tests during baby showers targets HIV diagnosis (b) church-based Health Advisors (CHAs) trained in motivational interviewing and quality improvement skills as promotoras target linkage, engagement and adherence by providing counseling and other support to HIV-infected women and children (c) integrated network of community and clinic case management targets reduction in loss to follow-up. CHAs will support participants during the study period by being available to accompany them to clinic visits, review laboratory results and medications after clinic visits. They will be available to speak with them at intervals to see how they are doing either by phone or through home visits as they prefer. At each follow-up study visit, the trained CHA will review and collect data on participants' clinic visits, treatment, and laboratory results.
Eligibility Criteria
You may qualify if:
- HIV-infected pregnant women identified during baby showers programs at participating worship centers.
You may not qualify if:
- HIV-infected women already on treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catholic Caritas Foundation
Makurdi, Benue State, Nigeria
Related Publications (1)
Ezeanolue EE, Obiefune MC, Yang W, Obaro SK, Ezeanolue CO, Ogedegbe GG. Comparative effectiveness of congregation- versus clinic-based approach to prevention of mother-to-child HIV transmission: study protocol for a cluster randomized controlled trial. Implement Sci. 2013 Jun 8;8:62. doi: 10.1186/1748-5908-8-62.
PMID: 23758933BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Public Health and Pediatrics
Study Record Dates
First Submitted
January 6, 2017
First Posted
January 11, 2017
Study Start
July 1, 2016
Primary Completion
March 1, 2020
Study Completion
March 1, 2020
Last Updated
January 11, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share